These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27664925)

  • 1. Swelling behavior of cross-linked dextran hydrogels and preliminary Gliclazide release behavior.
    Bajpai SK; Chand N; Tiwari S; Soni S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):978-987. PubMed ID: 27664925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of anti-diabetic drug Gliclazide from poly(caprolactone)/poly(acrylic acid) hydrogels.
    Bajpai SK; Chand N; Soni S
    J Biomater Sci Polym Ed; 2015; 26(14):947-62. PubMed ID: 26135033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
    Barakat NS; Almurshedi AS
    J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
    Sharma VK; Mazumder B
    Int J Biol Macromol; 2014 May; 66():15-25. PubMed ID: 24530641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
    Asyarie S; Rachmawati H
    PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.
    Awasthi R; Kulkarni GT
    Drug Dev Ind Pharm; 2014 Mar; 40(3):398-408. PubMed ID: 23418961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
    Hussain T; Saeed T; Mumtaz AM; Javaid Z; Abbas K; Awais A; Idrees HA
    Acta Pol Pharm; 2013; 70(4):749-57. PubMed ID: 23923399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel gastroretentive floating particulate drug delivery system of gliclazide.
    Awasthi R; Kulkarni GT
    Curr Drug Deliv; 2012 Sep; 9(5):437-51. PubMed ID: 22920574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive bacterial cellulose-g-poly(acrylic acid-co-acrylamide) hydrogels for oral controlled release drug delivery.
    Mohd Amin MC; Ahmad N; Pandey M; Jue Xin C
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1340-9. PubMed ID: 23875787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of pH-sensitive methyl methacrylate-g-starch/hydroxypropylated starch hydrogels: in vitro and in vivo study on release of esomeprazole magnesium.
    Kumar P; Ganure AL; Subudhi BB; Shukla S
    Drug Deliv Transl Res; 2015 Jun; 5(3):243-56. PubMed ID: 25787732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model.
    Panda BP; Krishnamoorthy R; Bhattamisra SK; Shivashekaregowda NKH; Seng LB; Patnaik S
    Sci Rep; 2019 Nov; 9(1):17331. PubMed ID: 31758056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
    Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
    Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
    Barakat NS; Almurshedi AS
    J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication and characterization of a novel semi-interpenetrating network hydrogel based on sodium carboxymethyl cellulose and poly(methacrylic acid) for oral insulin delivery.
    Li S; Chen Z; Wang J; Yan L; Chen T; Zeng Q
    J Biomater Appl; 2020 Jul; 35(1):3-14. PubMed ID: 32216507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation.
    Prajapati SK; Tripathi P; Ubaidulla U; Anand V
    AAPS PharmSciTech; 2008; 9(1):224-30. PubMed ID: 18446485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release.
    Kumar S; Bhanjana G; Verma RK; Dhingra D; Dilbaghi N; Kim KH
    J Pharm Pharmacol; 2017 Feb; 69(2):143-150. PubMed ID: 28033667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.